Abstract:Introduction: Human basic fibroblast growth factor (hbFGF) is a highly valuable multifunctional protein that plays a crucial role in various biological processes. In this study, we aim to accomplish the scaling-up production of mature hbFGF (146aa) by implementing a high cell-density fermentation and purification process on a 500-L scale, thereby satisfying the escalating demands for both experimental research and clinical applications. Methods: The hbFGF DNA fragment was cloned into a mpET-3c vector containing a kanamycin resistance gene and then inserted into Escherichia coli BL21 (DE3) plysS strain. To optimize the yield of hbFGF protein, various fermentation parameters were systematically optimized using BOX-Behnken design and further validated in large-scale fermentation (500-L). Additionally, a three-step purification protocol involving CM-Sepharose, heparin affinity, and SP-Sepharose column chromatography was developed to separate and purify the hbFGF protein. Isoelectric focusing electrophoresis, MALDI-TOF/MS analysis, amino acid sequencing, CD spectroscopy, and Western blotting were performed to authenticate its identity. The biological efficacy of purified hbFGF was evaluated using an MTT assay as well as in a diabetic deep second-degree scald model. Results: The engineered strain was successfully constructed, exhibiting high expression of hbFGF and excellent stability. Under the optimized fermentation conditions, an impressive bacterial yield of 46.8 ± 0.3 g/L culture with an expression level of hbFGF reaching 28.2% ± 0.2% was achieved in 500-L scale fermentation. Subsequently, during pilot-scale purification, the final yield of purified hbFGF protein was 114.6 ± 5.9 mg/L culture with RP-HPLC, SEC-HPLC, and SDS-PAGE purity exceeding 98%. The properties of purified hbFGF including its molecular weight, isoelectric point (pI), amino sequence, and secondary structure were found to be consistent with theoretical values. Furthermore, the purified hbFGF exhibited potent mitogenic activity with a specific value of 1.05 ± 0.94 × 106 AU/mg and significantly enhanced wound healing in a deep second-degree scald wound diabetic rat model. Conclusion: This study successfully established a stable and efficient large-scale production process of hbFGF, providing a solid foundation for future industrial production.

[Research of the Feeding Strategy in the Fermentation of Recombinant Human Fibreblast Growth Factor Mutant].

Using a Kinetic Model That Considers Cell Segregation to Optimize Hegf Expression in Fed-Batch Cultures of Recombinant Escherichia Coli

Large-Scale Preparation of Highly Stable Recombinant Human Acidic Fibroblast Growth Factor in Escherichia coli BL21(DE3) plysS Strain

Research on the Expression of Recombinant Human Afgf Mutant in Escherichia Coli

Fed-batch Cultivation of Escherichia Coli YK537 (Paet-8) for Production of Phoa Promoter-Controlled Human Epidermal Growth Factor

Production of Human Epidermal Growth Factor in Fed-batch Culture of Acetate-tolerant Escherichia Coli

Enhanced Production of L-Tryptophan with Glucose Feeding and Surfactant Addition and Related Metabolic Flux Redistribution in the Recombinant Escherichia Coli

Improving the production of human-like collagen by pulse-feeding glucose during the fed-batch culture of recombinant Escherichia coli

High-level production of active human fibroblast growth factor 1 using a dual-promoter vector in Pichia pastoris

Fed-batch Production of Human-Like Collagen with Recombinant Escherichia Coil Using Feed-Up DO-transient Control

Improving the Expression of Recombinant Proteins in E. Coli BL21 (DE3) under Acetate Stress: an Alkaline Ph Shift Approach

Expression of Human Acidic Fibroblast Growth Factor in Pichia Pastoris

Expression and Activity Identification of Shortened Human Acidic Fibroblast Growth Factor

Optimization of Fed-batch Culture of Recombinant E.coli. for High Expression of Glucagon Like Peptide-1

Scaling up production of recombinant human basic fibroblast growth factor in an Escherichia coli BL21(DE3) plysS strain and evaluation of its pro-wound healing efficacy

Effects of acetic acid and its assimilation in fed-batch cultures of recombinant Escherichia coli containing human-like collagen cDNA

[The Effects of Different Glucose Feeding Modes on Hegf Production in an Excretory Recombinant Escherichia Coli K12 System].

Soluble Expression and Preparation of Recombinant Human Fibroblast Growth Factor 21 in E.coli

High and Stable Expression of an Analog of Human Basic Fibroblast Growth Factor in Escherichia Coli

[Optimization of fermentation of recombinant human Endostatin (rh-Endostatin) expression in Escherichia coli]

Human growth hormone production by high cell density fermentation of recombinant Escherichia coli